| Bioactivity | GIP/GLP-1 dual receptor agonist-1 (compound 4) is a GIP/GLP-1 receptor agonist. GIP/GLP-1 dual receptor agonist-1 can be used in the research of metabolic disorders and fatty liver diseases, including nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD)[1]. |
| Name | GIP/GLP-1 dual receptor agonist-1 |
| CAS | 2807481-02-1 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Brian Lian, et al. Compositions and methods for the treatment of metabolic and liver disorders. WO2022159395. |